date:Sep 28, 2012
Growth in DSMs human and animal nutrition cluster is set to continue after the company this morning indicated an ongoing commitment to broadening its portfolio and did not rule out probiotic and/or botanical acquisitions.
CEO and chairman of the managing board, Feike Sijbesma, emphasised portfolio and geographic expansion while noting, nutrition is the major part of our (9bn) business at 4.4bn.
Speaking at the annual Capital Markets Days event at DSM Nutritional Products base in Basel, Switzer